Palatin Technologies
Alka Kamra is an accomplished professional in the field of regulatory affairs and quality control, currently serving as Senior Manager of Regulatory Affairs at Palatin Technologies. Previously, Alka has held significant positions including Quality Control Technical Scientist at Eli Lilly and Company, Senior Scientist at Medarex, Development Scientist at ImClone Systems Incorporated, and Principal Scientist at Noninvasive Technologies. Alka's academic background includes a Ph.D. in Biochemistry from the Indian Institute of Technology, Delhi, where studies commenced in 1990 and are ongoing.
Palatin Technologies
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system.